Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL28199112 | 0.97 | TSHR (0.44) | TSHRCES2CES1ALDH1A1CYP3A4 | |
| Hydrogen Sulfide SCHEMBL28100301 | 0.97 | TSHR (0.44) | TSHRCES2CES1ALDH1A1CYP3A4 | |
| SCHEMBL9421248 | 0.84 | ALDH1A1 (0.45) | TSHRCES2CES1ALDH1A1CYP3A4 | |
| SCHEMBL8973947 | 0.81 | TSHR (0.50) | TSHRALDH1A1CYP3A4TP53IDO1 | |
| SCHEMBL1466981 | 0.80 | CYP3A4 (0.40) | TSHRALDH1A1CYP3A4TP53HSD17B10 | |
| SCHEMBL13550047 | 0.80 | TSHR (0.35) | TSHRCES1CYP3A4RAPGEF4MEN1 | |
| SCHEMBL22165559 | 0.80 | TSHR (0.35) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL29429741 | 0.80 | TSHR (0.35) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL29970978 | 0.80 | TSHR (0.44) | TSHRCES2CES1ALDH1A1CYP3A4 | |
| SCHEMBL28085542 | 0.80 | TSHR (0.35) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1362860-B1 | Method for producing tetrakis (fluoraryl)borate magnesium compound | NIPPON CATALYTIC CHEM IND (JP) | 2010-09-15 | — | — | EP | claimed |
| US-7205441-B2 | Method for producing tetrakis (fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-04-17 | — | — | US | claimed |
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-11-20 | — | — | US | claimed |
| EP-1362860-A1 | Method for producing tetrakis (fluoroaryl) borate magnesium compound | Nippon Shokubai Co., Ltd. (JP) | 2003-11-19 | — | — | EP | claimed |
| EP-0667328-B1 | Process for the preparation of aromatic fluoro compounds | CLARIANT GMBH (DE) | 1998-09-16 | — | — | EP | claimed |
| US-5498807-A | Process for the preparation of aromatic fluoro compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-03-12 | — | — | US | claimed |
| EP-0667328-A1 | Process for the preparation of aromatic fluoro compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-08-16 | — | — | EP | claimed |
| EP-1362860-B1 | Method for producing tetrakis (fluoraryl)borate magnesium compound | NIPPON CATALYTIC CHEM IND (JP) | 2010-09-15 | — | — | EP | disclosed |
| US-7205441-B2 | Method for producing tetrakis (fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-04-17 | — | — | US | disclosed |
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-11-20 | — | — | US | disclosed |
| EP-1362860-A1 | Method for producing tetrakis (fluoroaryl) borate magnesium compound | Nippon Shokubai Co., Ltd. (JP) | 2003-11-19 | — | — | EP | disclosed |
| CN-1041197-C | Substituted 2-chloro-3,4,5-trifluorobenzenes and a process for their preparation | HOECHST AG (DE) | 1998-12-16 | — | — | CN | disclosed |
| EP-0667328-B1 | Process for the preparation of aromatic fluoro compounds | CLARIANT GMBH (DE) | 1998-09-16 | — | — | EP | disclosed |
| US-5498807-A | Process for the preparation of aromatic fluoro compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-03-12 | — | — | US | disclosed |
| CN-1112917-A | Substituted 2-chloro-3,4,5-trifluorobenzenes and a process for their preparation | HOECHST AG (DE) | 1995-12-06 | — | — | CN | disclosed |
| EP-0667328-A1 | Process for the preparation of aromatic fluoro compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | KRAS, MGAM, CA3 | TSHR 410/4885CES2 3957/4885CES1 4605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.